For instance, circ-HIPK3 was reported as an oncogene in prostate cancer [19], hepatocellular carcinoma [20] and colorectal cancer [21], but as a tumor inhibitor in osteosarcoma [22], ovarian cancer [23] and bladder cancer [24]. This evidence concerns the gene HIPK3 and prostate cancer.